Cargando…

Prognostic Significance and Functional Relevance of Olfactomedin 4 in Early-Stage Hepatocellular Carcinoma

OBJECTIVES: Hepatocellular carcinoma (HCC) is a leading cancer-related cause of death. Unfortunately, recurrence is common even after curative treatment of early-stage patients, and no adjuvant treatment has yet been established. Aberrant expression of OLFM4 in human cancers has been reported; yet,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Liangtao, Kriegl, Lydia, Reiter, Florian P., Munker, Stefan M., Itzel, Timo, Teufel, Andreas, Ziesch, Andreas, Török, Helga Paula, Kirchner, Thomas, Gerbes, Alexander L., Guba, Markus, Mayerle, Julia, De Toni, Enrico N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7056049/ https://www.ncbi.nlm.nih.gov/pubmed/31990698 http://dx.doi.org/10.14309/ctg.0000000000000124

Ejemplares similares

The PI3K inhibitor copanlisib synergizes with sorafenib to induce cell death in hepatocellular carcinoma
por: Ye, Liangtao, et al.
Publicado: (2019)

Comparative Response of HCC Cells to TKIs: Modified in vitro Testing and Descriptive Expression Analysis
por: Sagmeister, Paula, et al.
Publicado: (2022)

p70 Ribosomal Protein S6 Kinase Is a Checkpoint of Human Hepatic Stellate Cell Activation and Liver Fibrosis in Mice
por: Reiter, Florian P., et al.
Publicado: (2021)

Response to Chen et al.
por: Ye, Liangtao, et al.
Publicado: (2020)

Microsatellite Instability, KRAS Mutations and Cellular Distribution of TRAIL-Receptors in Early Stage Colorectal Cancer
por: Kriegl, Lydia, et al.
Publicado: (2012)

Olfactomedin 4 associates with expression of differentiation markers but not with properties of cancer stemness, EMT nor metastatic spread in colorectal cancer
por: Jaitner, Stefanie, et al.
Publicado: (2022)

Olfactomedin proteins: central players in development and disease
por: Anholt, Robert R. H.
Publicado: (2014)

Olfactomedin 4 as a circulating biomarker for asthma
por: Jang, An-Soo
Publicado: (2022)

Inactivation of BRCA2 in human cancer cells identifies a subset of tumors with enhanced sensitivity towards death receptormediated apoptosis
por: De Toni, Enrico N., et al.
Publicado: (2016)

Olfactomedin-4 in digestive diseases: A mini-review
por: Wang, Xin-Yu, et al.
Publicado: (2018)

Olfactomedin 4 marks a subset of neutrophils in mice
por: Alder, Matthew N, et al.
Publicado: (2018)

TRAIL Receptor Targeting Agents Potentiate PARP Inhibitor Efficacy in Pancreatic Cancer Independently of BRCA2 Mutation Status
por: Ben Khaled, Najib, et al.
Publicado: (2022)

Olfactomedin-like 3: possible functions in embryonic development and tumorigenesis
por: Jin, Ying, et al.
Publicado: (2019)

The Psychosocial Burden on Liver Transplant Recipients during the COVID-19 Pandemic
por: Weber, Sabine, et al.
Publicado: (2021)

Deep View of HCC Gene Expression Signatures and Their Comparison with Other Cancers
por: Qian, Yuquan, et al.
Publicado: (2022)

LEF-1 and TCF4 expression correlate inversely with survival in colorectal cancer
por: Kriegl, Lydia, et al.
Publicado: (2010)

Molecular Details of Olfactomedin Domains Provide Pathway to Structure-Function Studies
por: Hill, Shannon E., et al.
Publicado: (2015)

Olfactomedin 4 deletion induces colon adenocarcinoma in Apc(Min/+) mice
por: Liu, W, et al.
Publicado: (2016)

Design and structural characterisation of olfactomedin-1 variants as tools for functional studies
por: Pronker, Matti F., et al.
Publicado: (2019)

Up-regulation of c-MYC and SIRT1 expression correlates with malignant transformation in the serrated route to colorectal cancer
por: Kriegl, Lydia, et al.
Publicado: (2012)

Tivantinib (ARQ 197) affects the apoptotic and proliferative machinery downstream of c-MET: role of Mcl-1, Bcl-xl and Cyclin B1
por: Lu, Shuai, et al.
Publicado: (2015)

Ipilimumab and nivolumab in advanced hepatocellular carcinoma after failure of prior immune checkpoint inhibitor-based combination therapies: a multicenter retrospective study
por: Roessler, Daniel, et al.
Publicado: (2022)

Amassin, an olfactomedin protein, mediates the massive intercellular adhesion of sea urchin coelomocytes
por: Hillier, Brian J., et al.
Publicado: (2003)

Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma
por: Duan, Chao, et al.
Publicado: (2014)

Olfactomedin-1 Has a V-shaped Disulfide-linked Tetrameric Structure
por: Pronker, Matti F., et al.
Publicado: (2015)

Olfactomedin 4 (OLFM4) expression is associated with nodal metastases in esophageal adenocarcinoma
por: Suzuki, Lucia, et al.
Publicado: (2019)

Olfactomedin-3 Enhances Seizure Activity by Interacting With AMPA Receptors in Epilepsy Models
por: Tang, Shirong, et al.
Publicado: (2020)

High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer
por: Ohkuma, Ryotaro, et al.
Publicado: (2020)

Serum levels of olfactomedin 4: a biomarker for asthma control state in asthmatics
por: Chen, Xingyuan, et al.
Publicado: (2020)

Hepamine - A Liver Disease Microarray Database, Visualization Platform and Data-Mining Resource
por: Itzel, Timo, et al.
Publicado: (2020)

Loss of TRAIL-Receptors Is a Recurrent Feature in Pancreatic Cancer and Determines the Prognosis of Patients with No Nodal Metastasis after Surgery
por: Gallmeier, Eike, et al.
Publicado: (2013)

CellLineNavigator: a workbench for cancer cell line analysis
por: Krupp, Markus, et al.
Publicado: (2013)

Association Between Olfactomedin 4 and Postoperative Prognosis in Patients With Early-Stage Hepatocellular Carcinoma
por: Chen, Wan-Yuan, et al.
Publicado: (2020)

Olfactomedin 4 downregulation is associated with tumor initiation, growth and progression in human prostate cancer
por: Li, Hongzhen, et al.
Publicado: (2019)

Olfactomedin 4 as a novel loop of Henle‐specific acute kidney injury biomarker
por: Hasson, Denise C., et al.
Publicado: (2022)

Advances in Pharmacotherapy of Hepatocellular Carcinoma: A State-of-the-Art Review
por: Reiter, Florian P., et al.
Publicado: (2022)

Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression
por: Stallhofer, Johannes, et al.
Publicado: (2022)

Biophysical Characterization of the Olfactomedin Domain of Myocilin, an Extracellular Matrix Protein Implicated in Inherited Forms of Glaucoma
por: Orwig, Susan D., et al.
Publicado: (2011)

Olfactomedin 4 deficiency promotes prostate neoplastic progression and is associated with upregulation of the hedgehog-signaling pathway
por: Li, Hongzhen, et al.
Publicado: (2015)

Longitudinal characterization of olfactomedin-4 expressing neutrophils in pediatric patients undergoing bone marrow transplantation
por: Stark, Julie E., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_man6ha1iq8qn3e6p2tju0ucspg